Skip to main content
Premium Trial:

Request an Annual Quote

Waters Completes NuGenesis Acquisition

NEW YORK, March 5 (GenomeWeb News) - Waters announced today that it has completed its acquisition of Westborough, Mass.-based NuGenesis Technologies.

 

The mass spectrometer and chromatography vendor announced in January that it would acquire the bioinformatics company for $43 million.

 

Waters said that in line with the acquisition, it will be revealing plans for its informatics businesses at the Pittcon conference in Chicagonext week.

 

"With the 2003 acquisition of Croen Lab Control and the more recent purchase of NuGenesis Tehcnologies, Waters now has a comprehensive range of products for scientific data management. We are now much more thanan instrument company," Waters' president, Art Caputo, commented in a statement.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.